Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

E-ISSN： 1875-533x|16|9|1115-1121

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.9, 2009-03, pp. : 1115-1121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ABT-450: A Novel Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Current Medicinal Chemistry, Vol. 21, Iss. 28, 2014-09 ,pp. : 3261-3270

Bentham Science Publishers

Access to resources Recommend Favorite

The investigational hepatitis C virus (HCV) protease inhibitor telaprevir [VX 950] appears to be effective and well tolerated

Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection

By Gentile Ivan Buonomo Antonio Riccardo Borgia Federico Zappulo Emanuela Castaldo Giuseppe Borgia Guglielmo

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 719-728

Informa Healthcare

Access to resources Recommend Favorite

Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection

By Sheldon Julie Barreiro Pablo Vincent Vincent

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1171-1181

Informa Healthcare

Access to resources Recommend Favorite

Telaprevir for the treatment of hepatitis C

By Forestier Nicole Zeuzem Stefan

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 593-606

Informa Healthcare

Access to resources Recommend Favorite